TD Cowen analyst Tara Bancroft reiterated a Buy rating on Bicycle Therapeutics (NASDAQ: BCYC).The analyst commented, "At ESMO, zele's 45 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE